Gilead Sciences (GILD) Stock Price
$107.4 0.6%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
9 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Gilead Sciences, AI stock picks, stock alerts and much more.
GILD AI Stock Analysis
AI stock analysis for GILD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Gilead Sciences (GILD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Gilead Sciences (GILD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Gilead Sciences (GILD), currently trading at $107.4, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GILD
-
Gilead Sciences, Inc.
-
Symbol
GILD
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
133.8B
Similar Stocks
 |
Astrazeneca AZN |
$73.74 0.5% |
5 |
 |
Amgen AMGN |
$310.3 1.3% |
5 |
 |
Sanofi SNY |
$56.01 0.1% |
5 |
 |
Biogen BIIB |
$140.9 0.5% |
4 |
News
GILD Alternative Data
Web Traffic
Gilead Sciences receives an estimated 572844 monthly visitors to gilead.com.
-
Web Traffic
572844
-
Change from Previous Month
3.1%
-
3 Month Change
42.3%
-
YoY Change
42.3%
News Mentions
Gilead Sciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
75%
Reddit Mentions
Gilead Sciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
Twitter Followers
Gilead Sciences has 72,921 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
72921
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Gilead Sciences has engaged 37 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
37
-
Daily Change
14%
-
1 Month Change
23.3%
-
3 Month Change
9.8%
-
YoY Change
9.8%
Youtube Subscribers
Gilead Sciences has 5,650 subscribers on its main Youtube channel, up by 0.4% over the last month.
-
Youtube Subscribers
5650
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.4%
-
YoY Change
1.4%
LinkedIn Followers
681,150 are following Gilead Sciences on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
681150
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
3.2%
Job Postings
Gilead Sciences has an estimated 269 open job postings, which is down -27.9% over the last month.
-
Job Postings
269
-
Daily Change
3.6%
-
1 Month Change
27.9%
-
3 Month Change
45%
-
YoY Change
45%
LinkedIn Employees
According to LinkedIn, Gilead Sciences has 14,736 employees, up by 0.2% over the last month.
-
LinkedIn Employees
14736
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Business Outlook
According to employee reviews, the business outlook among employees at Gilead Sciences is 64 out of 100 (bullish).
-
Business Outlook
64
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
GILD Financials
GILD Key Metrics
-
Total Revenue
$7.6B
-
Net Income
$1.8B
-
Earnings per Share
$1.43
-
Free cash flow
$3B
-
EBITDA
$2.5B
-
EBITDA Ratio
0.323821
-
Total Assets
$59B
GILD 2-year Revenue & Income
GILD 2-year Free Cash Flow
GILD Technicals
GILD SMA
GILD RSI
FAQ
What's the current price of Gilead Sciences (GILD) Stock?
The price of an Gilead Sciences (GILD) share is $107.4.
What's the market cap of Gilead Sciences?
The current market cap of Gilead Sciences is 133.8B.
Should I buy or sell GILD?
Gilead Sciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Gilead Sciences is better viewed as a hold or accumulate position while waiting for further developments.
Is Gilead Sciences a good investment?
The current analysis of Gilead Sciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Gilead Sciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Gilead Sciences (GILD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Gilead Sciences stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Gilead Sciences (GILD) that investors often compare it to?
Gilead Sciences (GILD) is often compared to similar stocks such as Astrazeneca, Amgen, Sanofi and Biogen.
What is the forecast for Gilead Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Gilead Sciences' stock price to be around $109.5 in 2026. Starting from the current price of $107.4, this represents a 1.9% change in price, indicating a neutral outlook for the stock.
How to buy Gilead Sciences (GILD) Stock?
Gilead Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Gilead Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.